Published in Clin Exp Immunol on April 01, 1984
Chronic cough in a hospital population; its relationship to atopy and defects in host defence. Arch Dis Child (1989) 1.16
Immunoglobulin G subclass responses to mycobacterial lipoarabinomannan in HIV-infected and non-infected patients with tuberculosis. Clin Exp Immunol (1993) 1.12
The IgG4 subclass is associated with a low affinity antibody response to tetanus toxoid in man. Immunology (1985) 1.05
Immunoglobulin subclass distribution of human anti-carbohydrate antibodies: aberrant pattern in IgA-deficient donors. Immunology (1985) 1.03
Evaluation of test immunisation in the assessment of antibody deficiency syndromes. Br Med J (Clin Res Ed) (1984) 0.98
Enhanced IgG1 and IgG3 responses to pneumococcal polysaccharides in isolated IgA deficiency. Clin Exp Immunol (1989) 0.95
Antibody levels after regular childhood vaccinations in the immunological screening of children with recurrent otitis media. J Clin Immunol (2004) 0.86
An investigation into the effect of the IgG antibody system on the susceptibility of IgA-deficient patients to respiratory tract infections. Clin Exp Immunol (1986) 0.81
Lymphadenopathy and selective IgA deficiency. Br Med J (Clin Res Ed) (1984) 0.75
Antibody responses to tetanus toxoid in patients with primary biliary cirrhosis. J Clin Pathol (1987) 0.75
Specific Antibody Deficiency: Controversies in Diagnosis and Management. Front Immunol (2017) 0.75
The biology and detection of immune complexes. Adv Immunol (1979) 3.05
Pulmonary host defenses. I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with pseudomonas aeruginosa. J Immunol (1973) 2.25
Pulmonary host defenses. II. Interaction of respiratory antibodies with Pseudomonas aeruginosa and alveolar macrophages. J Immunol (1973) 1.92
Bovine antigens and the formation of circulating immune complexes in selective immunoglobulin A deficiency. J Clin Invest (1979) 1.47
Immunological abnormalities in bronchiectasis with chronic bronchial suppuration. Br J Dis Chest (1978) 1.36
Antibody deficiency syndrome: a case with normal immunoglobulin levels. Clin Exp Immunol (1968) 1.22
Mechanism of mucosal immunity to viral infections in gammaA immunoglobulin-deficiency syndromes. Proc Soc Exp Biol Med (1974) 1.21
Immunologic studies in patients with recurrent bronchopulmonary infections. Am Rev Respir Dis (1975) 1.16
In vitro analysis of humoral immunity in antibody deficiency with normal immunoglobulins. Clin Immunol Immunopathol (1980) 1.03
Antibody deficiency with normal immunoglobulins. J Pediatr (1979) 0.93
Immunological status of patients with recurrent chest infections. Lung (1978) 0.86
Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. Br J Psychiatry (2000) 4.44
Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms. BMJ (2001) 3.81
Amelogenin-deficient mice display an amelogenesis imperfecta phenotype. J Biol Chem (2001) 3.50
14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet (1987) 2.68
The prevalence and trends of overweight, obesity and nutrition-related non-communicable diseases in the Arabian Gulf States. Obes Rev (2011) 2.37
Supervision registers for mentally ill people. BMJ (1994) 2.14
Prevalence of substance misuse in first-episode psychosis. Br J Psychiatry (1999) 2.09
Care-seeking for fatal illnesses in young children in Indramayu, west Java, Indonesia. Lancet (1993) 2.02
Serum IgG subclass concentrations in healthy adults: a study using monoclonal antisera. Clin Exp Immunol (1984) 1.99
Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther (1992) 1.99
Patterns and predictors of hospitalisation in first-episode psychosis. Prospective cohort study. Br J Psychiatry (2001) 1.87
The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr Scand (2006) 1.76
Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Q J Med (1993) 1.74
Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party. Br J Haematol (1997) 1.72
Pathways to care and ethnicity. 1: Sample characteristics and compulsory admission. Report from the AESOP study. Br J Psychiatry (2005) 1.70
Matrix metalloproteinase-1 and skin ageing in smokers. Lancet (2001) 1.69
Helicobacter pylori eradication in patients with peptic ulcer disease: clinical consequences and financial implications. Q J Med (1994) 1.67
Is food insufficiency associated with health status and health care utilization among adults with diabetes? J Gen Intern Med (2001) 1.61
Characteristics of outcome in schizophrenia at 13 years. Br J Psychiatry (1995) 1.60
The Ty1-copia group retrotransposons in Vicia species: copy number, sequence heterogeneity and chromosomal localisation. Mol Gen Genet (1996) 1.59
A modified fascia iliaca compartment block has significant morphine-sparing effect after total hip arthroplasty. Anaesth Intensive Care (2007) 1.58
Omeprazole and Helicobacter pylori: temporary suppression rather than true eradication. Aliment Pharmacol Ther (1991) 1.56
Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychol Med (2000) 1.48
Systematic assessments of need and care planning in severe mental illness: cluster randomised controlled trial. Br J Psychiatry (2004) 1.47
Long-term follow-up of schizophrenia in 16 countries. A description of the International Study of Schizophrenia conducted by the World Health Organization. Soc Psychiatry Psychiatr Epidemiol (1996) 1.44
Premorbid personality in first-onset psychosis. Br J Psychiatry (1994) 1.42
Post-traumatic stress disorder. Br J Psychiatry (1990) 1.40
Chain shortening of palmitic acid in human subjects. Am J Clin Nutr (1988) 1.39
Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol (1993) 1.39
Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease? AIDS (1998) 1.38
Cerebral mass lesions due to cytomegalovirus in patients with AIDS: report of two cases. J Infect (1995) 1.38
Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis. Clin Exp Immunol (1984) 1.37
Long-term retrograde amnesia...the crucial role of the hippocampus. Neuropsychologia (2001) 1.31
Nutrition transition in the United Arab Emirates. Eur J Clin Nutr (2011) 1.29
The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study. Br J Haematol (2000) 1.28
Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART. HIV Med (2002) 1.26
"Eradication" of Campylobacter pylori: are we being misled? Lancet (1988) 1.26
High altitude pulmonary edema and exercise at 4,400 meters on Mount McKinley. Effect of expiratory positive airway pressure. Chest (1985) 1.23
Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: a case report. AIDS (1997) 1.22
Psychiatric hospital admissions in Bristol. I. Geographical and ethnic factors. Br J Psychiatry (1984) 1.19
The roles of annexins and types II and X collagen in matrix vesicle-mediated mineralization of growth plate cartilage. J Biol Chem (2000) 1.17
Pathways to care and ethnicity. 2: Source of referral and help-seeking. Report from the AESOP study. Br J Psychiatry (2005) 1.17
Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk? QJM (2003) 1.16
Investigating whether adverse prenatal and perinatal events are associated with non-clinical psychotic symptoms at age 12 years in the ALSPAC birth cohort. Psychol Med (2009) 1.16
Reinfection or recrudescence after apparently successful eradication of Helicobacter pylori infection: implications for treatment of patients with duodenal ulcer disease. Q J Med (1993) 1.15
Diagnostic stability of first-episode psychosis. Comparison of ICD-10 and DSM-III-R systems. Br J Psychiatry (1999) 1.15
Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy. J Clin Virol (2001) 1.11
Exposure to blood borne infections in health care workers. Med J Aust (1992) 1.10
Genetic regulation of autoimmune disease: BALB/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis. J Immunol (2001) 1.10
Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. Br J Haematol (2001) 1.08
Incidence of schizophrenia in Nottingham. A comparison of two cohorts, 1978-80 and 1992-94. Br J Psychiatry (1997) 1.07
CNS-directed therapy for childhood acute lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials. J Clin Oncol (2003) 1.06
Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapy. J Infect Dis (2001) 1.05
The IgG4 subclass is associated with a low affinity antibody response to tetanus toxoid in man. Immunology (1985) 1.05
A sensitive radioimmunoassay, incorporating solid-phase extraction, for fluticasone 17-propionate in plasma. J Pharm Biomed Anal (1993) 1.05
Impact of karyotype on treatment outcome in acute myeloid leukemia. Ann Hematol (2004) 1.04
The absent pulmonary valve syndrome. Considerations of management. Circulation (1978) 1.03
Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori. Aliment Pharmacol Ther (1992) 1.02
Purification and characterization of an inducible dissimilatory type sulfite reductase from Clostridium pasteurianum. Arch Microbiol (1984) 1.02
Unilateral pulmonary vein atresia: Diagnosis and treatment. Am J Cardiol (1975) 1.02
Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party. Leukemia (1999) 1.02
Protein losing enteropathy due to systemic lupus erythematosus. Gut (1984) 1.02
Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party. Leukemia (2002) 1.01
The Ty1-copia group retrotransposons of Allium cepa are distributed throughout the chromosomes but are enriched in the terminal heterochromatin. Chromosome Res (1996) 1.00
Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia. Br J Haematol (1997) 1.00
Helicobacter pylori infection treated with a tripotassium dicitrato bismuthate and metronidazole combination. Aliment Pharmacol Ther (1990) 0.99
Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations. Hum Immunol (1990) 0.99
Novel sensitive real-time PCR for quantification of bacterial 16S rRNA genes in plasma of HIV-infected patients as a marker for microbial translocation. J Clin Microbiol (2011) 0.98
Annexin V-mediated calcium flux across membranes is dependent on the lipid composition: implications for cartilage mineralization. Biochemistry (1997) 0.98
Schizophrenia in Nottingham: lifelong residential mobility of a cohort. Br J Psychiatry (1993) 0.97
Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic lupus erythematosus. J Clin Lab Immunol (1985) 0.96
Evaluating the Health of the Nation Outcome Scales. Reliability and validity in a three-year follow-up of first-onset psychosis. Br J Psychiatry (1999) 0.96
The Nottingham Acute Bed Study: alternatives to acute psychiatric care. Br J Psychiatry (1997) 0.95
Epidemiology of late presentation of HIV infection in Western Australia. Med J Aust (1992) 0.95
Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays. J Clin Lab Immunol (1983) 0.95
The association of fetal and childhood growth with risk of schizophrenia. Cohort study of 720,000 Swedish men and women. Schizophr Res (2005) 0.95
Antibiotic resistance in bacteria from magpies (Pica pica) and rabbits (Oryctolagus cuniculus) from west Wales. Environ Microbiol (2001) 0.94
Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease. J Antimicrob Chemother (2006) 0.93
Improved outcome of acute myeloid leukaemia in Down's syndrome. Arch Dis Child (1999) 0.93
Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment. Arch Dis Child (2001) 0.93
The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards - a cluster randomized controlled trial. Psychol Med (2007) 0.93
An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy. Clin Exp Immunol (2001) 0.93
Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity. J Immunol Methods (2012) 0.92
Sexual histories, attitudes, and behavior of schizophrenic and "normal" women. Arch Sex Behav (1984) 0.92
Successful pregnancy following steroid therapy and plasma exchange in a woman with anti-Ro (SS-A) antibodies. Case report. Br J Obstet Gynaecol (1987) 0.92
Flow cytometric analysis of the cytotoxic effects of Actinobacillus actinomycetemcomitans leukotoxin on human natural killer cells. J Leukoc Biol (1994) 0.91
The course of schizophrenia over 13 years. A report from the International Study on Schizophrenia (ISoS) coordinated by the World Health Organization. Br J Psychiatry (1996) 0.91
Immunoglobulin G subclass distribution of autoantibodies in systemic sclerosis, primary biliary cirrhosis, and overlap syndromes. Ann Rheum Dis (1987) 0.91
MHC haplotypes affect the expression of opportunistic infections in HIV patients. Hum Immunol (2001) 0.91
Variability of post-void residual urine volume in the elderly. Urol Res (1996) 0.91
Combined analysis of two-year follow-up from two open-label randomized trials comparing efficacy of three nucleoside reverse transcriptase inhibitor backbones for previously untreated HIV-1 infection: OzCombo 1 and 2. HIV Clin Trials (2003) 0.90